Mangoceuticals (MGRX) Responds to and Refutes Recent Claims Made by Eli Lilly

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. SPOT
6. BYD
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Mangoceuticals (MGRX) Responds to and Refutes Recent Claims Made by Eli Lilly

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

October 21, 2024 5:10 PM EDT

Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (MangoRx or the Company), a company focused on developing, marketing, and selling mens health and wellness products via a secure telemedicine platform learned earlier this morning that Eli Lilly has made certain public claims alleging, and has stated that it has filed a lawsuit against MangoRx claiming, that MangoRx improperly copied its weight-loss medicine, Zepbound and Mounjaro. MangoRx strongly refutes any and all claims made by Eli Lilly regarding the sale of compounded tirzepatide. MangoRx believes it has strong arguments against Eli... More